Nurse Practitioner in Gaithersburg, MD Accepting Medicare
88 Nurse Practitioner nurses found. Showing 81 - 88
 Alba Cogliandolo, FNP-C Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 806 W Diamond Ave Ste 110, Gaithersburg, MD 20878 Phone: 301-515-2901 |
Mrs. Lisa Samantha Housen Washington, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 610 E Diamond Ave, Suite 300, Gaithersburg, MD 20877 Phone: 240-790-3334 Fax: 301-820-7479 |
Catheline Odia, FNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 63 Inkberry Cir, Gaithersburg, MD 20877 Phone: 917-476-3757 |
Megan Davis Schollenberger, CRNP Nurse Practitioner - Primary Care Medicare: Accepting Medicare Assignments Practice Location: 800 S Frederick Ave, Gaithersburg, MD 20877 Phone: 301-664-6464 Fax: 855-386-5633 |
Daria Elizabeth Szelag, CPNP Nurse Practitioner - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 555 Quince Orchard Rd, Suite 350, Gaithersburg, MD 20878 Phone: 301-926-3633 |
Kristin Mctighe, Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 882 Muddy Branch Rd, Gaithersburg, MD 20878 Phone: 888-808-6483 |
 John Mccarthy, CRNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 21034 Woodfield Rd, Gaithersburg, MD 20882 Phone: 301-509-4150 |
Olga V Varnacheva, NP Nurse Practitioner - Primary Care Medicare: Accepting Medicare Assignments Practice Location: 204 Ridgepoint Pl, Gaithersburg, MD 20878 Phone: 832-331-4862 Fax: 301-330-0444 |
News Archive
Less nutritious diet mainly contributes to Type 2 diabetes among U.S.-based South Asians
Less nutritious dietary choices made by South Asians living in developed countries like the U.S. are a key contributor to the group's rising rate of Type 2 diabetes, UT Southwestern researchers report.
TAXIS Pharmaceuticals, Rutgers and UMDNJ to develop and commercialize a novel antimicrobial technology
TAXIS Pharmaceuticals, Inc. (TAXIS), Rutgers, The State University of New Jersey, and the University of Medicine and Dentistry of New Jersey (UMDNJ) have entered into an exclusive licensing agreement for worldwide rights to develop and commercialize a novel antimicrobial technology addressing multidrug-resistant (MDR) bacterial infections.
New review questions safety of estrogen replacement therapy
Although individuals often consume natural products because of their potential health benefits, a new review indicates that it is not clear whether the benefits of plant-derived compounds that mimic estrogen outweigh the possible health risks.
InterveXion receives federal grants for development of drug therapies to treat methamphetamine users
A University of Arkansas for Medical Sciences BioVentures startup company, InterveXion Therapeutics LLC, has received two federal grants totaling $14.5 million for development of drug therapies that can help methamphetamine drug abusers break their addiction.
New way of delivering corrective genes holds promise for hereditary diseases of the heart
A new way of delivering corrective genes with a single injection into a vein holds promise for long-lasting treatments of hereditary diseases of the heart, University of Florida researchers report.
› Verified 9 days ago